Medicina Nuclear. Diagnóstico de la patología de tiroides y paratiroides
Resumen Introducción y objetivo: La Medicina Nuclear tiene un papel destacado en el estudio de la patología de tiroides y paratiroides. El objetivo de este trabajo es realizar una revisión de las técnicas de imagen disponibles actualmente en Medicina Nuclear, para el estudio de dicha patología. Síntesis: La gammagrafía de tiroides sigue siendo una técnica útil en el estudio de la patología tiroidea, como, por ejemplo, en el nódulo tiroideo o el hipotiroidismo congénito. El SPECT-CT mejora el diagnóstico, frente al rastreo corporal total (RCT) con radioyodo, en pacientes con cáncer diferenciado de tiroides y cambia el manejo terapéutico, a la vez que, añadido a la gammagrafía de paratiroides, ayuda a la planificación de la cirugía, sobre todo en adenomas ectópicos. El PET-CT con 18F-FDG y con otros trazadores, tiene un papel relevante en varias indicaciones y tipos histológicos de cáncer de tiroides, aunque principalmente en la sospecha de recidiva. Así mismo, el PET-CT con fluorocolina es una alternativa excelente, con cifras elevadas de localización exitosa, en los casos de hiperparatiroidismo primario (HPTp) con pruebas convencionales negativas. Conclusiones: Con los avances técnicos de los últimos años en el ámbito de la Medicina Nuclear y, particularmente, con la imagen híbrida, se ha mejorado el estudio de la patología tiroidea, fundamentalmente del cáncer de tiroides, así como la localización prequirúrgica del HPTp.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
1. Díaz García C, De Haro Del Moral FJ. Visión de conjunto del diagnóstico médico por la Imagen. En: Técnicas de exploración en Medicina Nuclear. Barcelona: Masson; 2005. p. 1-21.
2. Diaz García C, De Haro Del Moral FJ. Tomografía por emisión de positrones. En: Técnicas de exploración en Medicina Nuclear. Barcelona: Masson; 2005. p. 329-42.
3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
4. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of Malignancy in Thyroid Incidentalomas Detected by 18 F-Fluorodeoxyglucose Positron Emission Tomography: A Systematic Review. Thyroid. 2012;22(9):918-25.
5. Gharib H, Papini E, Paschke R, Duick D, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2010;16(Suppl 1):1-43.
6. ACR-SNM-SPR Practice Guideline for the performance of Thyroid scintigraphy and uptake measurements. [Fecha de última actualización: 2009; Fecha de nuestra consulta: 24 jun 2019] Disponible en: http://snmmi.files.cms-plus.com/docs/Thyroid_Scintigraphy_1382732120053_10.pdf.
7. Jacob H, Peters C. Screening, diagnosis and management of congenital hypothyroidism: European Society for Paediatric Endocrinology Consensus Guideline. Arch Dis Child Educ Pract Ed. 2015;100(5):260-3.
8. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism. J Clin Endocrinol Metab. 2014;99(2):363-84.
9. Xue YL, Qiu ZL, Song HJ, Luo QY. Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. Eur J Nucl Med Mol Imaging. 2013;40(5):768-78.
10. Zilioli V, Peli A, Panarotto MB, Magri G, Alkraisheh A, Wiefels C, et al. Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy. Endocrine. 2017;56(3):551-9.
11. Muros de Fuentes MA, Mitjavila Casanovas M, Estorch Cabrera M, Lecumberri Santamaria B, Navarro González E. Utilidad de la 18F-FDG PET/TC en el cáncer de tiroides. Rev Esp Med Nucl Imagen Mol. 2016;35(3):186-92.
12. Feine U, Lietzenmayer R, Hanke JP, Wöhrle H and Müller-Schauenburg W. 18FDG whole body PET in differentiated thyroid carcinoma. Flip-flop in uptake patterns of 18FDG and 131I. Nuklearmedizin. 1995; 34(4):127-34.
13. Wan Q, Bai L, Zhao G, Zhang Y, Ma Q, Wang R, et al. Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis. Eur J Endocrinol. 2019; 181 (2): 93-102
14. Haddad RI, Bischoff L, Busaidy NL, Callender G, Dickson P, Duh QY et al. NCCN Clinical Practice guidelines in Oncology. Thyroid carcinoma. Version 1.2019. Disponible en: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf
15. Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(suppl 7):vii110-9.
16. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2012;22(11):1104-39.
17. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surgery. 2016;151(10):959-68.
18. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9.
19. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JEM, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19.
20. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, et al. SNM Practice Guideline for Parathyroid Scintigraphy 4.0. J Nucl Med Technol. 2012;40(2):111-8.
21. Hindié E, Ugur Ö, Fuster D, ODoherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36(7):1201-16.
22. García-Talavera P, Díaz-Soto G, Montes AA, Villanueva JG, Cobo A, Gamazo C, et al. Contribution of early SPECT/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: Diagnostic value and correlation between uptake and biological parameters. Rev Esp Med Nucl Imagen Mol. 2016;35(6):351-7.
23. Prats E, Razola P, Tardín L, Andrés A, García López F, Abós MD, et al. Parathyroid scintigraphy and radioguided surgery in primary hyperparathyroidism. Rev Esp Med Nucl. 2007;26(5):310-28.
24. Wei WJ, Shen CT, Song HJ, Qiu ZL, and Luo QY. Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta-analysis. Hell J Nucl Med. 2015; 18 (2):127-35.
25. Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43(1):78-83.
26. Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2019;46(3):751-65.
27. Garcia-Talavera P, García-Talavera JR. Radio-Guided Surgery and Intraoperative iPTH Determination in the Treatment of Primary Hyperparathyroidism. En: Diaz Soto G, editor. Hyperparathyroidism [Internet]. Rijeka (Croatia): InTech; 2012 [citado 6 de julio de 2019]. Disponible en: http://www.intechopen.com/books/hyperparathyroidism/radio-guided-surgery-and-intraoperative-ipth-determination-in-the-treatment-of-primary-hyperparathyr
2. Diaz García C, De Haro Del Moral FJ. Tomografía por emisión de positrones. En: Técnicas de exploración en Medicina Nuclear. Barcelona: Masson; 2005. p. 329-42.
3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
4. Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L. Risk of Malignancy in Thyroid Incidentalomas Detected by 18 F-Fluorodeoxyglucose Positron Emission Tomography: A Systematic Review. Thyroid. 2012;22(9):918-25.
5. Gharib H, Papini E, Paschke R, Duick D, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract. 2010;16(Suppl 1):1-43.
6. ACR-SNM-SPR Practice Guideline for the performance of Thyroid scintigraphy and uptake measurements. [Fecha de última actualización: 2009; Fecha de nuestra consulta: 24 jun 2019] Disponible en: http://snmmi.files.cms-plus.com/docs/Thyroid_Scintigraphy_1382732120053_10.pdf.
7. Jacob H, Peters C. Screening, diagnosis and management of congenital hypothyroidism: European Society for Paediatric Endocrinology Consensus Guideline. Arch Dis Child Educ Pract Ed. 2015;100(5):260-3.
8. Léger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism. J Clin Endocrinol Metab. 2014;99(2):363-84.
9. Xue YL, Qiu ZL, Song HJ, Luo QY. Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. Eur J Nucl Med Mol Imaging. 2013;40(5):768-78.
10. Zilioli V, Peli A, Panarotto MB, Magri G, Alkraisheh A, Wiefels C, et al. Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy. Endocrine. 2017;56(3):551-9.
11. Muros de Fuentes MA, Mitjavila Casanovas M, Estorch Cabrera M, Lecumberri Santamaria B, Navarro González E. Utilidad de la 18F-FDG PET/TC en el cáncer de tiroides. Rev Esp Med Nucl Imagen Mol. 2016;35(3):186-92.
12. Feine U, Lietzenmayer R, Hanke JP, Wöhrle H and Müller-Schauenburg W. 18FDG whole body PET in differentiated thyroid carcinoma. Flip-flop in uptake patterns of 18FDG and 131I. Nuklearmedizin. 1995; 34(4):127-34.
13. Wan Q, Bai L, Zhao G, Zhang Y, Ma Q, Wang R, et al. Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis. Eur J Endocrinol. 2019; 181 (2): 93-102
14. Haddad RI, Bischoff L, Busaidy NL, Callender G, Dickson P, Duh QY et al. NCCN Clinical Practice guidelines in Oncology. Thyroid carcinoma. Version 1.2019. Disponible en: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf
15. Pacini F, Castagna MG, Brilli L, Pentheroudakis G. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(suppl 7):vii110-9.
16. Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, et al. American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2012;22(11):1104-39.
17. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surgery. 2016;151(10):959-68.
18. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9.
19. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JEM, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017;28(1):1-19.
20. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, et al. SNM Practice Guideline for Parathyroid Scintigraphy 4.0. J Nucl Med Technol. 2012;40(2):111-8.
21. Hindié E, Ugur Ö, Fuster D, ODoherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36(7):1201-16.
22. García-Talavera P, Díaz-Soto G, Montes AA, Villanueva JG, Cobo A, Gamazo C, et al. Contribution of early SPECT/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: Diagnostic value and correlation between uptake and biological parameters. Rev Esp Med Nucl Imagen Mol. 2016;35(6):351-7.
23. Prats E, Razola P, Tardín L, Andrés A, García López F, Abós MD, et al. Parathyroid scintigraphy and radioguided surgery in primary hyperparathyroidism. Rev Esp Med Nucl. 2007;26(5):310-28.
24. Wei WJ, Shen CT, Song HJ, Qiu ZL, and Luo QY. Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta-analysis. Hell J Nucl Med. 2015; 18 (2):127-35.
25. Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013;43(1):78-83.
26. Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2019;46(3):751-65.
27. Garcia-Talavera P, García-Talavera JR. Radio-Guided Surgery and Intraoperative iPTH Determination in the Treatment of Primary Hyperparathyroidism. En: Diaz Soto G, editor. Hyperparathyroidism [Internet]. Rijeka (Croatia): InTech; 2012 [citado 6 de julio de 2019]. Disponible en: http://www.intechopen.com/books/hyperparathyroidism/radio-guided-surgery-and-intraoperative-ipth-determination-in-the-treatment-of-primary-hyperparathyr
García-Talavera, P., Diaz-González, L. G., Martín-Gómez, E., Peñaherrera-Cepeda, A. C., López-Puche, S., & Tamayo-Alonso, P. (2019). Medicina Nuclear. Diagnóstico de la patología de tiroides y paratiroides. Revista ORL, 11(3), 283–295. https://doi.org/10.14201/orl.21496
Artículos más leídos del mismo autor/a
- Pilar Tamayo-Alonso, Paloma Garcia-Talavera, Enrique Martín-Gómez, Jose Cañadas-Salazar, Luis Gonzaga Díaz-González, Tratamiento con radioyodo de la patología tiroidea , Revista ORL: Vol. 11 Núm. 3 (2020)
- Pilar Tamayo-Alonso, Esther Martín-Gómez, Paloma García-Talavera, José Cañadas-Salazar, Carolina Peñaherrera-Cepeda, Luis Gonzaga Díaz-González, Actualización del tratamiento del cáncer de tiroides con radioyodo , Revista ORL: Vol. 12 Núm. 4 (2021)
- Esther Martín-Gómez, Paloma Garcia-Talavera, Luis Gonzaga Díaz-González, Enrique Martín-Gómez, Sara López-Puche, Pilar Tamayo-Alonso, Técnicas diagnósticas de Medicina Nuclear en patología tiroidea: relación con los grupos TIRADS y citología Bethesda , Revista ORL: Vol. 12 Núm. 4 (2021)
- Luis Gonzaga Díaz-González, Paloma Garcia-Talavera, Felipe Gomez-Caminero, Cristina Riola-Parada, Juan Gabriel Villanueva-Curto, Pilar Tamayo-Alonso, PET en el diagnóstico de la patología de tiroides , Revista ORL: Vol. 11 Núm. 3 (2020)
- Paloma García-Talavera, Luis Gonzaga Díaz-González, Felipe Gómez-Caminero, Enrique Martín Gómez, José Cristóbal Cañadas-Salazar, Pilar Tamayo-Alonso, Nuevas técnicas de Medicina Nuclear en la cirugía del hiperparatiroidismo , Revista ORL: Vol. 12 Núm. 4 (2021)
- Paloma García-Talavera San Miguel, Luis Gonzaga Díaz-González, Felipe Gómez-Caminero, Cristina Riola Parada, Carolina Peñaherrera-Cepeda, María Pilar Tamayo-Alonso, PET-CT en el carcinoma anaplásico de tiroides y otros subtipos histológicos agresivos , Revista ORL: Vol. 13 Núm. 2 (2022)
- Pilar Tamayo-Alonso, Paloma García-Talavera, Carlos Montes-Fuentes, Esther Martín-Gómez, Enrique Martín-Gómez, Luis Díaz-González, Evolución del tratamiento con radioyodo en el carcinoma diferenciado de tiroides , Revista ORL: Vol. 13 Núm. 2 (2022)
- Luis Gonzaga Díaz-González, Berta Pérez-López, Yoana Franco-Rodríguez, Ángel Muñoz-Herrera, Pilar Tamayo-Alonso, Paraganglioma mediastínico detectado con gammagrafía SPECT-TC con 111In-pentetreótida. Descripción de un caso , Revista ORL: Vol. 8 Núm. 4 (2017)
Descargas
Los datos de descargas todavía no están disponibles.
+
−